-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
-
Summary
-
Rubius Therapeutics, Inc. quarterly/annual General and Administrative Expense history and growth rate from Q2 2017 to Q4 2022.
- Rubius Therapeutics, Inc. General and Administrative Expense for the quarter ending December 31, 2022 was $1.06M, a 92.4% decline year-over-year.
- Rubius Therapeutics, Inc. General and Administrative Expense for the twelve months ending December 31, 2022 was $30.8M, a 41.9% decline year-over-year.
- Rubius Therapeutics, Inc. annual General and Administrative Expense for 2022 was $30.8M, a 41.9% decline from 2021.
- Rubius Therapeutics, Inc. annual General and Administrative Expense for 2021 was $53M, a 5.34% increase from 2020.
- Rubius Therapeutics, Inc. annual General and Administrative Expense for 2020 was $50.3M, a 12% decline from 2019.
General and Administrative Expense, Trailing 12 Months (USD)
General and Administrative Expense, Quarterly (USD)
General and Administrative Expense, YoY Quarterly Growth (%)